阿托伐他汀联合肠溶阿司匹林对颈动脉粥样硬化患者血清TNFαIL6水平的影响临床医学（临床医学资料）.doc

阿托伐他汀联合肠溶阿司匹林对颈动脉粥样硬化患者血清TNFαIL6水平的影响临床医学（临床医学资料） 文档信息 主题： 关于“医学心理学”中“临床医学”的参考范文。 属性： F-01NHU0，doc格式，正文24750字。质优实惠，欢迎下载！ 适用： 作为医学资料、临床医学资料写作的参考文献，解决如何写好实用应用文、正确编写文案格式、内容摘取等相关工作。 目录 TOC \o 1-9 \h \z \u 目录 1 正文 1 文1：阿托伐他汀联合肠溶阿司匹林对颈动脉粥样硬化患者血清TNFαIL6水平的影响临床医学 2 1 资料与方法 3 2 结果 4 3 讨论 4 文2：乙型肝炎后肝硬化患者血清IL┐6IL┐8和TNF┐α水平变化的意义医学 5 1对象和方法 7 参考文摘引言： 10 原创性声明（模板） 12 文章致谢（模板） 12 正文 阿托伐他汀联合肠溶阿司匹林对颈动脉粥样硬化患者血清TNFαIL6水平的影响临床医学（临床医学资料） 文1：阿托伐他汀联合肠溶阿司匹林对颈动脉粥样硬化患者血清TNFαIL6水平的影响临床医学 [ABSTRACT] Objective: To observe the influence of atorvastatin combining with entericcoated aspirin on serum tumor necrosis factor α (TNFα) and interleukincell 6 (IL6) levels in patients with carotid atherosclerosis. Methods: A total of 125 patients with carotid atherosclerosis were randomly assigned to treatment group (64 cases) and control group (61 cases), which were treated with atorvastatin combining with entericcoated aspirin and atorvastatin alone separately. Six months after the treatment, compared the progress of atherosclerosis and TNFα, IL6 levels between the two groups. Results: After treatment, perimete including the average carotid plaque volume, carotid artery lumen diameter, mean patch size and serum TNFα, IL6 levels were significantly decreased in both groups (P); which was more obviously in the treatment group except for the carotid artery lumen diameter (P). Conclusion: Atorvastatin combining with entericcoated aspirin can significantly inhibit the progress of carotid atherosclerosis by adjusting inflammatory cytokine levels and suppressing inflammatory injuries. [KEY WORDS] Atorvastatin; Entericcoated aspirin; Carotid artery atherosclerosis; Tumor necrosis factorα; Interleukin6 cells 颈动脉粥样硬化(CAA)为导致缺血性脑血管病的主要原因之一[1]。研究表明,采取调脂、抗炎、抗血小板聚集等干预措施均具有不同程度预防及治疗动脉粥样硬化的作用。2009年1月～2010年1月,我们对125例脑梗塞患者进行颈动脉超声检查,发现有颈动脉硬化斑块者给予阿托伐他汀联合肠溶阿司匹林治疗,取得良好效果,现报道如下。 1 资料与方法 一般资料 全部病例均来自我院门诊或住院患者，采用随机数字表法分为两组，治疗组64例，男性36例，女性28例;平均年龄(±)岁;病程15～172d。对照组61例，男性39例，女性22